Skip to content

Application effect of an abdominal radiotherapy marker line protector in patients undergoing abdominal tumor radiotherapy

Application effect of an abdominal radiotherapy marker line protector in patients undergoing abdominal tumor radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105321
Enrollment
Unknown
Registered
2025-07-02
Start date
2024-12-09
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Observers group:Use abdominal radiotherapy marker line protector
Control group:Use traditional sterile transparent dressings for external application

Sponsors

The First People's Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Abdominal tumor patients receiving radiotherapy; 2. All meet the indications for radiation therapy and require marking lines to be drawn; 3. Nurses guide patients on corresponding precautions and have them check the marked lines before radiotherapy every day; 4. Patient or family members participate and sign the informed consent form for this project;

Exclusion criteria

Exclusion criteria: 1. Individuals allergic to silicone products; 2. Individuals with mental, cognitive, language, hearing, and visual impairments who are unable to communicate; 3. Individuals with lower limb muscle strength less than level III; 4. Fever sufferers; 5. Those with unhealed abdominal wounds; 6. Individuals with severe damage to their liver, liver, and kidneys; 7. Those with poor compliance with medical practices;

Design outcomes

Primary

MeasureTime frame
The number of revalidations caused by the disappearance of radiation field marker lines;The radiotherapy marker line is unclear and needs to depict the average number of times per person;Patient comfort level;Patient satisfaction;The cost of radiotherapy marker lines during radiotherapy;Patient's skin adverse reactions (sweating, itching);

Countries

China

Contacts

Public ContactLuo Liqun

The First People's Hospital of Foshan

18038865022@163.com+86 757 83162533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026